BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6158677)

  • 1. [Immunochemical study of the conformational properties of the variable and constant domains of the light chain of mouse MOPC myeloma immunoglobulin].
    Petrosian MN; Vengerova TI; Rokhlin OV
    Mol Biol (Mosk); 1980; 14(5):1187-92. PubMed ID: 6158677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic markers of V domain of mouse MOPC 21 IgG1 L chain. The conformational basis of VL domain markers and content of MOPC 21 VL-like immunoglobulins in sera of inbred mouse strains.
    Rokhlin OV; Petrosyan MN; Ibraghimov AR; Vengerova TI; Bogachova GT
    Eur J Immunol; 1983 May; 13(5):397-403. PubMed ID: 6189726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antigenic markers of variable region of mouse myeloma MOPC 21 light chain].
    Vengerova TI; Petrosian MN; Bogacheva GT; Rokhlin OV
    Mol Biol (Mosk); 1979; 13(6):1303-11. PubMed ID: 94936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of lambda 1 and lambda 2 murine light chains by carrier-specific isologous T helper cells; effect of L-H chain assembly.
    Bogen B; Jørgensen T; Hannestad K
    Eur J Immunol; 1983 May; 13(5):353-9. PubMed ID: 6189725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-V region framework antibodies affect the ligand binding of VL dimer.
    Ben-Neriah Y; Givol D; Gavish M
    Eur J Immunol; 1979 Jan; 9(1):91-3. PubMed ID: 108113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved amino acid networks involved in antibody variable domain interactions.
    Wang N; Smith WF; Miller BR; Aivazian D; Lugovskoy AA; Reff ME; Glaser SM; Croner LJ; Demarest SJ
    Proteins; 2009 Jul; 76(1):99-114. PubMed ID: 19089973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of antibodies to the lambda chain variable region (Vlambda) of mouse immunoglobulins.
    Ben-Neriah Y; Lonai P; Gavish M; Givol D
    Eur J Immunol; 1978 Nov; 8(11):792-6. PubMed ID: 82511
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antigenic determinants of the constant region of human immunoglobin kappa-chain detected by monoclonal antibodies].
    Arsen'eva EL; Bogacheva GT; Solomon A; Rokhlin OV
    Mol Biol (Mosk); 1989; 23(5):1227-33. PubMed ID: 2481811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational isomerism, rotational allomerism, and divergent evolution in immunoglobulin light chains.
    Edmundson AB; Ely KR; Abola EE; Schiffer M; Panagiotopoulos N; Deutsch HF
    Fed Proc; 1976 Aug; 35(10):2119-23. PubMed ID: 820572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of anti-framework antibodies to the kappa-chain variable region (V kappa) of mouse immunoglobulins.
    Ben-Neriah Y; Lonai P; Givol D
    J Immunol; 1980 Feb; 124(2):691-5. PubMed ID: 6766163
    [No Abstract]   [Full Text] [Related]  

  • 11. The folding pathway of the antibody V(L) domain.
    Simpson ER; Herold EM; Buchner J
    J Mol Biol; 2009 Oct; 392(5):1326-38. PubMed ID: 19647749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folding of an antibody variable domain in two functional conformations in vitro: calorimetric and spectroscopic study of the anti-ferritin antibody VL domain.
    Tsybovsky Y; Shubenok DV; Kravchuk ZI; Martsev SP
    Protein Eng Des Sel; 2007 Oct; 20(10):481-90. PubMed ID: 17962224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric human-mouse IgG antibodies with shuffled constant region exons demonstrate that multiple domains contribute to in vivo half-life.
    Zuckier LS; Chang CJ; Scharff MD; Morrison SL
    Cancer Res; 1998 Sep; 58(17):3905-8. PubMed ID: 9731501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen binding and stability properties of non-covalently linked anti-CD22 single-chain Fv dimers.
    Arndt MA; Krauss J; Rybak SM
    FEBS Lett; 2004 Dec; 578(3):257-61. PubMed ID: 15589829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic dissection of a hapten binding site.
    Sen J; Beychok S
    Proteins; 1986 Nov; 1(3):256-62. PubMed ID: 3130623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complete V domain amino acid sequences of two myeloma inulin-binding proteins.
    Johnson N; Slankard J; Paul L; Hood L
    J Immunol; 1982 Jan; 128(1):302-7. PubMed ID: 6798111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of in vivo growth of murine plasmacytoma MOPC-460 by monoclonal anti-idiotypic antibodies directed at distinct idiotypes of the immunoglobulin on the surface of MOPC-460.
    Bridges SH; Le Guern C; Gurgo C
    Cancer Res; 1984 Nov; 44(11):5051-5. PubMed ID: 6488164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of the immunoglobulin light chain-binding site of protein L.
    Wikström M; Sjöbring U; Drakenberg T; Forsén S; Björck L
    J Mol Biol; 1995 Jul; 250(2):128-33. PubMed ID: 7608965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR analysis of the interaction between protein L and Ig light chains.
    Enokizono J; Wikström M; Sjöbring U; Björck L; Forsén S; Arata Y; Kato K; Shimada I
    J Mol Biol; 1997 Jul; 270(1):8-13. PubMed ID: 9231896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.